SIN3B and pancreatic neoplasm: Based on the differences observed between in vivo and in vitro experiments, as well as previous reported CRISPR screening result, we hypothesized that the inhibitory effect Sin3B loss on pancreatic cancer might rely on anti‐tumor immunity.